Latest tumor Stories
Combination Clinical Trial Data Showing Impressive Activity in Bone Cancer and Other Sarcomas LOS ANGELES, May 4, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical
Health System Joins Caris Centers of Excellence for Precision Medicine Network to Develop Guidelines and Standards of Care for Tumor Profiling IRVING,
Odds are, most people at one point in their childhood blamed their “evil twin” when something went wrong or was broken. But as it turns out, doctors recently discovered an Indiana woman’s brain tumor actually was caused by an “evil twin”...sort of.
- Company on track to file IND and initiate Phase 1 clinical trial in mid-2015 - CAMBRIDGE, Mass., April 24, 2015 /PRNewswire/ -- Blueprint Medicines today announced new preclinical data demonstrating
First-of-Its-Kind Liquid Biopsy Study Highlights Improved Quality of Care in 87 Percent of Cases REDWOOD CITY, Calif.
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
- End of Dose-Escalation Confirmed - VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar
Clinical benefit fueling strong adoption in liquid biopsy market REDWOOD CITY, Calif.
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind(TM) technology has successfully integrated single cell isolation and downstream